Prof. Dr. med. Pietro Vernazza
Nevirapine in HIV maintenance therapy - can "old drugs" survive in current HIV management?
Notter J, Bregenzer A, Vernazza P, Kahlert C. Nevirapine in HIV maintenance therapy - can "old drugs" survive in current HIV management?. Swiss Med Wkly 2019; 149:w20053.
Apr 24, 2019Nevirapine in HIV maintenance therapy - can "old drugs" survive in current HIV management?
Apr 24, 2019Swiss Med Wkly 2019; 149:w20053
Notter Julia, Bregenzer Andrea, Vernazza Pietro, Kahlert Christian
The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study
Young J, Bucher H, Günthard H, Vernazza P, Hachfeld A, Cavassini M, Bernasconi E, Tarr P, Calmy A, Scherrer A, Swiss HIV Cohort Study. The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study. Antivir Ther (Lond) 2019
Apr 15, 2019The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study
Apr 15, 2019Antivir Ther (Lond) 2019
Young Jim, Bucher Heiner C, Günthard Huldrych F, Vernazza Pietro, Hachfeld Anna, Cavassini Matthias, Bernasconi Enos, Tarr Philip E, Calmy Alexandra, Scherrer Alexandra U, Swiss HIV Cohort Study
Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection
Carlisle L, Braun D, Rauch A, Calmy A, Cavassini M, Battegay M, Vernazza P, Bernasconi E, Günthard H, Kouyos R, Perreau M, Klimkait T, Yerly S, Turk T, Kusejko K, Metzner K, Leemann C, Schenkel C, Bachmann N, Posada S, Beerenwinkel N, Böni J, Swiss HIV Cohort Study. Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection. J Infect Dis 2019
Mar 4, 2019Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection
Mar 4, 2019J Infect Dis 2019
Carlisle Louisa A, Braun Dominique L, Rauch Andri, Calmy Alexandra, Cavassini Matthias, Battegay Manuel, Vernazza Pietro, Bernasconi Enos, Günthard Huldrych F, Kouyos Roger D, Perreau Matthieu, Klimkait Thomas, Yerly Sabine, Turk Teja, Kusejko Katharina, Metzner Karin J, Leemann Christine, Schenkel Corinne, Bachmann Nadine, Posada Susana, Beerenwinkel Niko, Böni Jürg, Swiss HIV Cohort Study
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, Mullhaupt B, Negro F, Semela D. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions. Swiss Med Wkly 2019; 149:w14694.
Jan 23, 2019Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Jan 23, 2019Swiss Med Wkly 2019; 149:w14694
Rusch Urs, Robbins Sarah, Razavi Homie, Vernazza Pietro, Blach Sarah, Bruggmann Philip, Mullhaupt Beat, Negro Francesco, Semela David
Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?
Kahlert C, Wagner N, Staehelin C, Rudin C, Paioni P, Nadal D, Martinez de Tejada B, Bernasconi E, Aebi-Popp K, Vernazza P. Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?. Swiss Med Wkly 2018; 148:w14648.
Jul 23, 2018Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting?
Jul 23, 2018Swiss Med Wkly 2018; 148:w14648
Kahlert Christian, Wagner Noémie, Staehelin Cornelia, Rudin Christoph, Paioni Paolo, Nadal David, Martinez de Tejada Begoña, Bernasconi Enos, Aebi-Popp Karoline, Vernazza Pietro
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
Yerly S, Marzolini C, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert C, Hösli I, Hoffmann M, Hirsch H, Hasse B, Metzner K, Müller N, Weber R, Wandeler G, Vernazza P, Trkola A, Tarr P, Stöckle M, Speck R, Schmid P, Scherrer A, Rudin C, Rauch A, Paioni P, Pantaleo G, Nicca D, Haerry D, Günthard H, Fux C, Kouyos R, Günthard H, Hoffmann M, Furrer H, Cavassini M, Calmy A, Bernasconi E, Battegay M, Klimkait T, Aubert V, Yerly S, Böni J, Kadelka C, Bachmann N, Swiss HIV Cohort Study, Aubert V, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Ciuffi A, Cavassini M, Calmy A, Bucher H, Braun D, Böni J, Bernasconi E, Battegay M, Turk T. Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. Elife 2017; 6
Sep 12, 2017Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
Sep 12, 2017Elife 2017; 6
Yerly S, Marzolini C, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R D, Klimkait T, Keiser O, Kaiser L, Kahlert Christian, Hösli I, Hoffmann M, Hirsch H H, Hasse B, Metzner K J, Müller N, Weber R, Wandeler G, Vernazza Pietro, Trkola A, Tarr P, Stöckle M, Speck R, Schmid Patrick, Scherrer A U, Rudin C, Rauch A, Paioni P, Pantaleo G, Nicca D, Haerry D, Günthard H F, Fux C A, Kouyos Roger D, Günthard Huldrych F, Hoffmann Matthias, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Aubert Vincent, Yerly Sabine, Böni Jürg, Kadelka Claus, Bachmann Nadine, Swiss HIV Cohort Study, Aubert V, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Ciuffi A, Cavassini M, Calmy A, Bucher H C, Braun D L, Böni J, Bernasconi E, Battegay M, Turk Teja
Adverse events of raltegravir and dolutegravir
Elzi L, Battegay M, Bernasconi E, Günthard H, Vernazza P, Calmy A, Cavassini M, Furrer H, Erb S. Adverse events of raltegravir and dolutegravir. AIDS 2017; 31:1853-1858.
Aug 24, 2017Adverse events of raltegravir and dolutegravir
Aug 24, 2017AIDS 2017; 31:1853-1858
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Günthard Huldrych, Vernazza Pietro, Calmy Alexandra, Cavassini Matthias, Furrer Hansjakob, Erb Stefan
Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial
Carreño J, Pérez Shibayama C, Gil Cruz C, López-Macías C, Vernazza P, Ludewig B, Albrich W. Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial. PloS one 2017; 12:e0178669.
Jun 1, 2017Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial
Jun 1, 2017PloS one 2017; 12:e0178669
Carreño Juan Manuel, Pérez Shibayama Christian Ivan, Gil Cruz Cristina, López-Macías Constantino, Vernazza Pietro, Ludewig Burkhard, Albrich Werner
Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study
Mayer L, Kahlert C, Rassouli F, Vernazza P, Albrich W. Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study. Pneumonia (Nathan) 2017; 9:4.
Feb 25, 2017Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study
Feb 25, 2017Pneumonia (Nathan) 2017; 9:4
Mayer Lena M, Kahlert Christian, Rassouli Frank, Vernazza Pietro, Albrich Werner
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
Gueler A, Egger M, Zwahlen M, Vernazza P, Cavassini M, Battegay M, Fux C, Furrer H, Bernasconi E, Günthard H, Calmy A, Moser A. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS 2016
Nov 7, 2016Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
Nov 7, 2016AIDS 2016
Gueler Aysel, Egger Matthias, Zwahlen Marcel, Vernazza Pietro, Cavassini Matthias, Battegay Manuel, Fux Christoph A, Furrer Hansjakob, Bernasconi Enos, Günthard Huldrych F, Calmy Alexandra, Moser André
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions
Salazar-Vizcaya L, Rauch A, Keiser O, Egger M, Furrer H, Vernazza P, Calmy A, Bernasconi E, Darling K, Battegay M, Wandeler G, Zahnd C, Kouyos R. Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions. Hepatology 2016; 64:1856-1869.
Oct 19, 2016Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions
Oct 19, 2016Hepatology 2016; 64:1856-1869
Salazar-Vizcaya Luisa, Rauch Andri, Keiser Olivia, Egger Matthias, Furrer Hansjakob, Vernazza Pietro, Calmy Alexandra, Bernasconi Enos, Darling Katharine Elizabeth Anna, Battegay Manuel, Wandeler Gilles, Zahnd Cindy, Kouyos Roger D
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
Rodger A, Prins J, Rieger A, Stoeckle M, Kümmerle T, Bini T, Ammassari A, Gilson R, Krznaric I, Ristola M, Zangerle R, Handberg P, Antela A, Allan S, Phillips A, Lundgren J, Wandeler G, Westling K, Weber R, Cambiano V, Bruun T, Vernazza P, Collins S, Van Lunzen J, Corbelli G, Estrada V, Geretti A, Beloukas A, Asboe D, Viciana P, Gutiérrez F, Clotet B, Pradier C, Gerstoft J. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA 2016; 316:171-81.
Jul 12, 2016Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
Jul 12, 2016JAMA 2016; 316:171-81
Rodger Alison J, Prins Jan M, Rieger Armin, Stoeckle Marcel, Kümmerle Tim, Bini Teresa, Ammassari Adriana, Gilson Richard, Krznaric Ivanka, Ristola Matti, Zangerle Robert, Handberg Pia, Antela Antonio, Allan Sris, Phillips Andrew N, Lundgren Jens, Wandeler Gilles, Westling Katarina, Weber Rainer, Cambiano Valentina, Bruun Tina, Vernazza Pietro, Collins Simon, Van Lunzen Jan, Corbelli Giulio Maria, Estrada Vicente, Geretti Anna Maria, Beloukas Apostolos, Asboe David, Viciana Pompeyo, Gutiérrez Félix, Clotet Bonaventura, Pradier Christian, Gerstoft Jan
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland
Shilaih M, Kouyos R, Günthard H, Furrer H, Bernasconi E, Vernazza P, Klimkait T, Cavassini M, Aubert V, Hirsch H, Yerly S, Böni J, Schüpbach J, Scherrer A, Yang W, Marzel A, Swiss HIV Cohort Study. Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland. Sci Rep 2016; 6:27580.
Jun 14, 2016Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland
Jun 14, 2016Sci Rep 2016; 6:27580
Shilaih Mohaned, Kouyos Roger, Günthard Huldrych F, Furrer Hansjakob, Bernasconi Enos, Vernazza Pietro, Klimkait Thomas, Cavassini Matthias, Aubert Vincent, Hirsch Hans H, Yerly Sabine, Böni Jürg, Schüpbach Jörg, Scherrer Alexandra U, Yang Wan Lin, Marzel Alex, Swiss HIV Cohort Study
Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis
Scherrer A, Günthard H, Bernasconi E, Vernazza P, Calmy A, Furrer H, Battegay M, Cavassini M, Aubert V, Klimkait T, Yerly S, Böni J, Kouyos R, Yang W, von Wyl V. Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis. Clin Infect Dis 2016
Mar 8, 2016Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis
Mar 8, 2016Clin Infect Dis 2016
Scherrer Alexandra U, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Calmy Alexandra, Furrer Hansjakob, Battegay Manuel, Cavassini Matthias, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Kouyos Roger, Yang Wan-Lin, von Wyl Viktor
HIV screening: better communication instead of searching for a needle in a haystack?
Vernazza P. HIV screening: better communication instead of searching for a needle in a haystack?. Swiss Med Wkly 2016; 146:w14224.
Jan 31, 2016HIV screening: better communication instead of searching for a needle in a haystack?
Jan 31, 2016Swiss Med Wkly 2016; 146:w14224
Vernazza Pietro
HIV is not transmitted under fully suppressive therapy: The Swiss Statement - eight years later
Vernazza P, Bernard E. HIV is not transmitted under fully suppressive therapy: The Swiss Statement - eight years later. Swiss Med Wkly 2016; 146:w14246.
Jan 29, 2016HIV is not transmitted under fully suppressive therapy: The Swiss Statement - eight years later
Jan 29, 2016Swiss Med Wkly 2016; 146:w14246
Vernazza Pietro, Bernard Edwin J
[Influenza – Not innocuous, but preventable]
Vernazza P. [Influenza – Not innocuous, but preventable]. Ther Umsch 2016; 73:231-4.
Jan 1, 2016[Influenza – Not innocuous, but preventable]
Jan 1, 2016Ther Umsch 2016; 73:231-4
Vernazza Pietro
Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy
Kahlert C, Bregenzer A, Gutmann C, Otterbech S, Hoffmann M, Schmid P, Vernazza P. Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy. Infection 2015
Dec 11, 2015Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy
Dec 11, 2015Infection 2015
Kahlert Christian, Bregenzer Andrea, Gutmann Christine, Otterbech Synove, Hoffmann Matthias, Schmid Patrick, Vernazza Pietro
In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine and Cerebro-Spinal Fluid
Aouri M, Rotger M, Telenti A, Buclin T, Günthard H, Vernazza P, Henry H, Yerly S, Anagnostopoulos A, Cavassini M, Ternon B, Barcelo C, Decosterd L. In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine and Cerebro-Spinal Fluid. Drug Metab Dispos 2015
Nov 9, 2015In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine and Cerebro-Spinal Fluid
Nov 9, 2015Drug Metab Dispos 2015
Aouri Manel, Rotger Margalida, Telenti Amalio, Buclin Thierry, Günthard Huldrych F, Vernazza Pietro, Henry Hugues, Yerly Sabine, Anagnostopoulos Alexia, Cavassini Matthias, Ternon Beatrice, Barcelo Catalina, Decosterd Laurent A
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy
Schmid P, Weber R, Opravil M, Vernazza P, Mullhaupt B, Jochum W, Rauch A, Huber M, Bregenzer A, Swiss HIV Cohort Study. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy. PloS one 2015; 10:e0138838.
Sep 29, 2015Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy
Sep 29, 2015PloS one 2015; 10:e0138838
Schmid Patrick, Weber Rainer, Opravil Milos, Vernazza Pietro, Mullhaupt Beat, Jochum Wolfram, Rauch Andri, Huber Milo, Bregenzer Andrea, Swiss HIV Cohort Study